By Thabiso Mutirwara mutirwarat@dailynews.co.zw THE World Health Organisation (WHO) will launch a clinical research study to assess the safety and efficacy of a new HIV vaccine in Zimbabwe and neighbouring South Africa this month. The vaccine, GRAD HIV-NE1, is said to spur a very strong immune response in people living with HIV/Aids — which could…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions